{"id":"tp-35904","type":"article-newspaper","title":"FDA Clears Alvotech Process to More Than Double Simlandi Drug Substance Output","author":"Riza Dagoc","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/regulation/35904","datePublished":"2026-10-20T19:33:25.000Z","dateModified":"2026-10-20T19:33:25.000Z","language":"en","abstract":"The process applies to Alvotech’s DSM2 manufacturing suite in Reykjavik, Iceland, which was previously cleared to supply drug substance for the U.S. market.","section":"Regulation","references":[]}